Preterm birth is not only one of the most common causes of infant deaths but also a great risk for them to have severe subsequent health problems. The causes of preterm birth may be due to a combination of genetic and environmental factors, however, it remains largely unknown. Here we report an untargeted lipidomics dataset of plasma specimens from 258 pregnant women at the stage of twelve to twenty-five gestational weeks. Among them, 44 had extremely to very preterm births, 54 had moderate preterm births, 71 had late preterm births and 89 had full-term deliveries. The metabolomic profiling was generated with an UPLC-MS in both the positive and negative mode, and putative identification of all the metabolites was provided by searching against online databases. The quality assessment performed on quality control samples showed that the data is reproducible, robust and reliable. Both the raw data files, the raw and processed data matrix were available on MetaboLights, which may be used as a valuable validation dataset for new findings and a test dataset for novel algorithms.
Background & Summary
Preterm birth (PTB) refers to delivery before 37 completed weeks of gestation, and it is one of the "Great Obstetrical Syndromes" 1 . The global incidence of PTB was 9.6%, and more than 1.17 million PTB happen in China each year, making the second largest PTB population 2 . PTB is the leading cause of neonatal mortality and morbidity, and more than one million babies die each year from PTB complications 2 . Premature babies have an increased chance to have complications such as breathing difficulties, underdeveloped organs, low birth weight, cerebral palsy, and vision or hearing problems. According to the gestational age of delivery, PTB is classified as extremely preterm (<28 weeks), very preterm (28-<32 weeks) and moderate preterm (32-<34 weeks) or late preterm (34-<37 weeks). The earlier the delivery happens, the more adverse the consequence is.
The cause of PTB is complicated, and it could result from infection, inflammation, stress, genetic factors or induced for medical reasons 3, 4 . Once preterm labor started, there is no sure way to stop it, but medical treatments could help to slow down the procedure and reduce the risk of premature birth complications. Although there are many tests using cervicovaginal fetal fibronectin (fFN) or transvaginal sonographic cervical length measurements to predict the risk of PTB, accurate prediction of PTB remains a challenging task 5 .
Lipids serving as fuel molecules, signal molecules and components of membranes components are important to pregnancy. There is a close relationship between PTB and progesterone, and weekly injection of 17 alpha-hydroxyprogesterone caproate could prevent recurrent preterm delivery 6, 7 . As the precursor of steroid hormones, maternal cholesterol concentration and its association with PTB has been investigated in many studies, and the results are controversial 8 .
The role of omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA) in pregnancy has also been studied, and cervical ripening and uterine contractions could be affected by the local concentration of specific fatty acids [9] [10] [11] . Randomized trials of total LCPUFA supplementation have been conducted and found a reduction in early PTB (<34 weeks) 10, 12, 13 . The secondtrimester serum lipid profiling of 35 PTB women and 35 matched term delivery controls were carried out, and increased levels of lipids and changes of key end-point metabolites were found in PTB women 14 . All these discoveries imply that lipids could play an important role in PTB and could be used as potential biomarkers for PTB or interventions to extend the length of pregnancy.
Currently, few studies have focused on the second-trimester plasma lipid profiling of PTB subtypes. Hence, we carried out untargeted lipid profiling of plasma from 258 second-trimester pregnant women, including 44 with extremely or very PTB, 54 with moderate PTB, 71 with late PTB, and 89 with full-term delivery. Reproducible, robust and reliable data were generated and available on MetaboLights, providing a valuable validation dataset for new findings and a test dataset for novel algorithms.
Methods

Preterm birth sample recruit
Pregnant women who underwent non-invasive prenatal tests (NIPT) and were willing to donate their samples for research were candidates for this study. Information of pregnancy, delivery and the baby was collected through telephone interview surveys, and samples meeting the following conditions were recruited: 1) singleton; 2) sampling between 13-26 gestational weeks;
3) live birth; 4) vaginal delivery; 5) no pregnancy complications; 6) no newborn anomalies.
Preterm birth subtypes were identified as follows: 24w-<32w as extremely or very preterm birth, 32w-<34w as moderate preterm birth, and 34w-<37w as late preterm birth. Women giving birth after 37 complete gestational weeks and with comparable sampling gestational age, maternal age, and baby gender were included as full-term birth. As a result, 44 extremely or very PTB, 54 moderate PTB, 71 late PTB, and 89 full-term delivery women were recruited. For this study, ethical approval was provided by the Institutional Review Board of BGI (FT 15142).
Plasma sample collection and sample management
Peripheral blood of pregnant women was taken into 5mL EDTA tubes, and plasma was separated through 2-step centrifugation. The blood tube was centrifuged for 10 min at 1,600g at 4 ℃ , and plasma was transferred and centrifuged for 10 min at 16,000g at 4 ℃ . The supernatant was isolated and stored at -80℃. A 600μL plasma sample each woman was used in the following procedure.
Extraction of lipids from the blood samples
The lipid extraction was performed following a previously published protocol 15 . Briefly, plasma samples stored at -80 °C were transferred to -20°C and kept for 30 minutes, thawed at 4 °C and placed on ice. Samples were randomized in order and vortexed for 5s to be homogenized. A 100 μL of each sample was aliquoted into an Eppendorf tube followed by 300 μL of ice-cold isopropanol. Samples were vortexed to mix for 1 minute and placed for 10 minutes at room temperature followed by rested overnight at -20 °C to deposit, after which they were centrifuged to remove the proteins (14000 g, 20 min, 4 °C). A 20 μL supernatant from each sample was transferred into new Eppendorf tubes and 180 μL 50% Methanol was added into each tube and vortexed for 1 minute. The samples were re-randomized and a 20 μL of all the test samples were pooled as a quality control sample (QC sample), which were used for the LC-MS system conditioning before acquisition of the test samples and the quality assessment of the generated data 16 . The QC and test samples were stored at -80 °C until further analysis.
UPLC-QTOF MS analysis
The UPLC system used was an ACQUITY UPLC (Waters, USA) and separations were performed on an Acquity UPLC CSH C18 column (2.1×100 mm, 1.7 μm, Waters), with a flow rate of 0.4 mL/min, and a column temperature of 35 °C throughout the experiment. A aliquot of Leucine enkephalin (LE), which was acquired every 3 seconds during the acquisition. Sample injection order was randomized and distributed into two batches. For each batch, QC samples were analysed ten times at the beginning and three times at the end to equilibrate the column.
During acquisition, QC samples were also analysed every ten samples.
LC-MS data processing
The peak picking and annotation of the MS features were performed on the progenesis QI 2.1 (Waters, Nonlinear Dynamics, USA. The peak picking procedure includes raw file import, peak detection, peak alignment, peak list deisotoping and grouping of adducts ( Fig. 1 ). For the peak detection, the minimal peak intensity was set to be 5000, and the noise ratio and peak width were set to auto in progenesis QI, which automatic optimized during peak detection. After evaluation of the stability of all the samples, the 20150330_POS_QC83 was chosen as a reference sample in positive mode and 20150406_NEG_QC33 in negative mode. All the rest samples were aligned to these two samples in retention time. For the peak grouping, the A data matrix contains m/z paired retention times and peaks intensity was acquired after progenesis QI processing, and the data matrix was further used for data quality assessment using metaX 17 (Fig.1) . First, features were filtered when their nonzero values are less than 50% of QC samples or removed if they detected in <80% of experimental samples to avoid exogenous impurity. After the filtering, the retained missing values were imputed by KNN 18 . Then the QC-RLSC 19 method was applied to correct each metabolic feature signal draft according to the signal change in QC samples and the PQN 20 was performed to normalize all the samples. The features with RSD >30% in QC samples were removed after the QC-RLSC and PQN correction to get clean data, in which unwanted variations were removed.
Putative annotation
The putative annotation of features was conducted by searching against online databases using accurate mass, isotope abundance and MS/MS fragmentation pattern using Progenesis QI. The 
Statistical analysis
Principal component analysis and relative standards deviations, which were employed for the quality assessment were performed using the R version 3.4.0.
Data Records
The raw data files in the .raw format generated from untargeted UPLC-MS profiling in both the positive and negative mode are submitted to the MetaboLights repository (Data Citation1:MetaboLights MTBLS885). The peak picking and annotation obtained from Progenesis QI 2.1 data processing were also contained in the deposited data, and a detailed explanation to the headers was provided within these tables. Furthermore, the raw data files and the processed results have also been submitted to CNSA (Data Citation 2: CNP0000369), researchers may download the raw data via FTP: https://db.cngb.org/. Raw data files and the corresponding raw peak tables, the processed peak tables and scripts are listed in Table 1 .
Technical Validation
The quality validation of lipids profiling was performed following the best practices of analytical methodologies 21, 22 . All the plasma samples were analysed in a random order, and the stability and reproducibility were evaluated by the pooled QC samples inserted into the analysis sequence during the whole experimental period, as shown in Fig. 2 . The data quality was measured in the following three ways: (1) Fig. 2E, F) , which was consistent with our expectation that pooled samples are most similar with each other, indicating the analysis process met the required qualifications.
Usage Notes
The raw data files in .raw format, the raw peak matrix, clean peak matrix, the putative identification list and a detailed explanation to the header of these files are available from MetaboLights (Data Citation 1) and the CNSA (Data Citation 2). Since the raw data were generated from MSE mode, a branch of the data independent acquisition, the MS-DIAL 23 and Progenesis QI, were recommended to redo the peak picking and identification. The instrument .raw files could be accessed directly using MassLynx or converted into .mzXML format using databridge and checked by the Mzmine 24 . The raw peak matrix files were generated from the raw files using Progensis QI, and gone through removing severe missing peaks, missing value imputation, batch effect correction, sample normalization and noise filtering to generate the clean peak matrix, which was further used for data quality validation using metaX. All the codes used in data cleaning were also uploaded to Metabolights. The clean peak matrix is assumed to be free of unwanted variation but still need to be log-transformed to correct the non-normal distribution before univariate or multivariate analysis. All together with the identification list, this dataset may be used as a reference dataset for the evaluation of potential biomarkers discovered by other studies, as well as validation evidence of the findings of other omics datasets. The raw spectra and the raw data matrix may contribute to the evaluation of novel spectra processing software and new algorithms/pipeline for data preprocessing. 
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